发明名称 DOSAGE FORM COMPRISING AN ACTIVE INGREDIENT AND A PLURALITY OF SOLID POROUS MICROCARRIERS
摘要 The present application provides a dosage form and related methods for making the dosage form. The dosage form generally comprises a hydrophilic active ingredient, a plurality of solid, porous microcarriers, each having a hydrophobic surface, an optional hydrophobic encapsulant, and a hydrophilic delivery agent, wherein (i) the hydrophilic active ingredient is associated with the plurality of solid, porous microcarriers, (ii) the plurality of solid, porous microcarriers is encapsulated by the hydrophobic encapsulant, and (iii) the hydrophilic delivery agent is physically separated from a majority of the hydrophilic active ingredient by a boundary between the hydrophilic delivery agent and the hydrophobic encapsulant. In some embodiments, the dosage form is for topical application. In some additional embodiments, the plurality of solid, porous microcarriers is formed by modifying the microcarriers to increase their hydrophobicity.
申请公布号 US2015125496(A1) 申请公布日期 2015.05.07
申请号 US201414532987 申请日期 2014.11.04
申请人 BioPharmX, Inc. 发明人 Yamamoto Akira
分类号 A61K47/02;A61K31/519;A61K47/34;A61K31/14;A61K9/00;A61K47/44;A61K31/65;A61K31/375 主分类号 A61K47/02
代理机构 代理人
主权项 1. A dosage form, comprising a hydrophilic active ingredient, a plurality of porous microcarriers, each having a hydrophobic surface, a hydrophobic encapsulant, and a hydrophilic delivery agent, wherein (i) the hydrophilic active ingredient is associated with the plurality of porous microcarriers,(ii) the plurality of solid, porous microcarriers is encapsulated by the hydrophobic encapsulant, and(iii) the associated active ingredient is partitioned from the hydrophilic delivery agent by a phase boundary between the hydrophobic encapsulant and the hydrophilic delivery agent.
地址 Menlo Park CA US